The BRC has recently provided support to assist in the clinical translation of a promising novel oral tolerance method to treat children with severe peanut allergy, which may have a major impact on clinical care in the shortmedium term (Clark AT et al. Successful oral tolerance induction in severe peanut allergy. Allergy. 2009;64:1218-20).



